Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 0.21Book Value per Share
VS
Market
Sector
Industry
History
$ 1.65Close
$ 0.39 - $ 1.81 52-Week Range
Ticker Information
Ticker
LCTXCompany Name
LINEAGE CELL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTLINEAGE CELL THERAPEUTICS INC - Book Value per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LCTX - BVPS Historical data
| Date | Book Value per Share | Shareholders Equity | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ 0.21 | $ 48.38M | 1 | 228.36M |
| 3/31/2025 | $ 0.35 | $ 79.03M | 1 | 226.05M |
| 12/31/2024 | $ 0.39 | $ 78.38M | 1 | 200.19M |
| 9/30/2024 | $ 0.35 | $ 66.19M | 1 | 188.84M |
| 6/30/2024 | $ 0.36 | $ 68.3M | 1 | 188.81M |
| 3/31/2024 | $ 0.4 | $ 72.4M | 1 | 182.91M |
| 12/31/2023 | $ 0.37 | $ 63.42M | 1 | 172.66M |
| 9/30/2023 | $ 0.39 | $ 68.12M | 1 | 174.87M |
| 6/30/2023 | $ 0.43 | $ 72.67M | 1 | 170.59M |
| 3/31/2023 | $ 0.41 | $ 70.45M | 1 | 170.13M |
Key Performance Insights, Last 5 Years
- LINEAGE CELL THERAPEUTICS INC's latest trailing twelve months (TTM) BVPS stands at $ 0.61.
- Over the past 5 years, LINEAGE CELL THERAPEUTICS INC's average BVPS has been $ 0.48.
- The median BVPS for LINEAGE CELL THERAPEUTICS INC during this period was $ 0.43
- LINEAGE CELL THERAPEUTICS INC reached its highest BVPS over the past 5 years at $ 0.77.
- The lowest BVPS recorded by LINEAGE CELL THERAPEUTICS INC in the same timeframe $ 0.21
LINEAGE CELL THERAPEUTICS INC's BVPS vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
BVPS Benchmarks
Similar metrics to Shares WA:
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Book Value per Share
[Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].Equity / (Shares WA * Share Factor)
(=) BVPS BVPS for LINEAGE CELL THERAPEUTICS INC is calculated as follows: Equity [ $ 91.27M ] / (Shares WA [ 149.97M ] * Share Factor [ 1 ])
(=) BVPS [ $ 0.61 ] LCTX - Book Value per Share, Last 5 years
$ 0.21
Minimum
Jun 30, 2025
$ 0.77
Maximum
Jun 30, 2021
$ 0.48
Average
$ 0.43
Median
BVPS Benchmark AnalysisMarket
The chart above depicts the distribution of BVPS for companies in the Total Stock Market. The average BVPS of the companies is $ 10.28 with a standard deviation of $ 12.44.
The following table provides additional summary stats:
BVPS in the Market:
| filtered constituents | 4K |
|---|---|
| min | $ -30.1 |
| max | $ 46.85 |
| average | $ 10.28 |
| median | $ 6.03 |
| std | $ 12.44 |